Back to catalogue
SEED
Seed Innovations Limited
420/1000 Overall fit
AI beneficiary 35% 35
Operating leverage 25% 25
Valuation 25% 58
Downside protection 15% 62
First-pass take
Closed-end investment vehicle (£11.8m NAV) trading at 73.8% discount to NAV, diversified across biotech (62% of portfolio) and fintech. Most holdings Level 3 (illiquid); top 3 represent 62% of NAV. Limited core AI exposure beyond Inveniam fintech and Juvenescence therapeutics. Net cash position (£3.4m) provides downside floor but execution risk on early-stage ventures material.
Flags
investment-vehiclemicro-capilliquid-portfolioportfolio-concentrationregulatory-riskstrading-discountno-core-ai-exposure